Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirin Kalimuddin

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Nature Communications|July 15, 2018
Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global disseminationMargaret M C Lam, Kelly L Wyres, Sebastian DuchĂȘne, et al.
Scientific Reports|April 15, 2021
Author Correction: The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subcloneSwaine L Chen, Ying Ding, Anucha Apisarnthanarak, et al.
Frontiers in Immunology|July 15, 2021
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of RemdesivirYi-Hao Chan, Barnaby E Young, Siew-Wai Fong, et al.
Scientific Reports|September 15, 2019
The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subcloneSwaine L Chen, Ying Ding, Anucha Apisarnthanarak, et al.
The New England Journal of Medicine|July 30, 2020
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human AntibodyJenny G Low, Justin H J Ng, Eugenia Z Ong, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 11, 2020
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B<sub>12</sub> in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)Chuen Wen Tan, Liam Pock Ho, Shirin Kalimuddin, et al.
The Journal of Infectious Diseases|September 30, 2019
Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?Kristen K Coleman, Chui Ching Wong, Jayanthi Jayakumar, et al.
Open Forum Infectious Diseases|May 12, 2017
A Report of Adult Human Adenovirus Infections in a Tertiary HospitalShirin Kalimuddin, Yvonne F Z Chan, Ian Q Wu, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Nature Communications|July 15, 2018
Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global disseminationMargaret M C Lam, Kelly L Wyres, Sebastian DuchĂȘne, et al.
Scientific Reports|April 15, 2021
Author Correction: The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subcloneSwaine L Chen, Ying Ding, Anucha Apisarnthanarak, et al.
Frontiers in Immunology|July 15, 2021
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of RemdesivirYi-Hao Chan, Barnaby E Young, Siew-Wai Fong, et al.
Scientific Reports|September 15, 2019
The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subcloneSwaine L Chen, Ying Ding, Anucha Apisarnthanarak, et al.
The New England Journal of Medicine|July 30, 2020
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human AntibodyJenny G Low, Justin H J Ng, Eugenia Z Ong, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 11, 2020
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B<sub>12</sub> in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)Chuen Wen Tan, Liam Pock Ho, Shirin Kalimuddin, et al.
The Journal of Infectious Diseases|September 30, 2019
Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?Kristen K Coleman, Chui Ching Wong, Jayanthi Jayakumar, et al.
Open Forum Infectious Diseases|May 12, 2017
A Report of Adult Human Adenovirus Infections in a Tertiary HospitalShirin Kalimuddin, Yvonne F Z Chan, Ian Q Wu, et al.
Pageof 10